Canada · Delayed Price · Currency is CAD EcoSynthetix Earnings Call Transcripts
Fiscal Year 2025
-
Sales grew 12% in 2025 with record volumes in strategic markets and first full year of positive Adjusted EBITDA. Strategic segments now drive over 70% of business, with strong pipelines and continued margin improvement expected in 2026.
-
Q3 2025 saw 11% sales growth, driven by strong demand in pulp, tissue, wood composites, and personal care. Key accounts are ramping up usage, with major opportunities in pulp and wood composites, while partnerships and industry trends support long-term growth.
-
Q2 2025 saw a 57% revenue increase and positive adjusted EBITDA, driven by strong growth in pulp and wood composites. Key strategic accounts expanded orders, and the company maintained a robust cash position while investing in share buybacks and operational improvements.
-
Q1 2025 saw a 14% sales decline due to broad market softness, but strategic accounts in pulp and wood composites advanced key initiatives and commercial orders. Gross margin fell to 27.2%, while cash reserves remained strong and R&D investment continued.
Fiscal Year 2024
-
Q4 and full-year 2024 saw strong revenue and volume growth, improved margins, and positive adjusted EBITDA, driven by strategic wins in pulp, wood composites, and personal care. The company maintains a robust cash position and is poised for further growth despite some early 2025 demand softness.
-
Q3 2024 delivered 38% sales growth and a return to profitability, driven by strong demand across all end markets and improved margins. Strategic progress in wood composites and pulp, along with disciplined capital management, positions the business for sustainable growth into 2025.
-
Q2 sales rose 8% year-over-year to $3.2 million, with volumes up 21% and gross margin improving to 31%. Robust trial activity and two new commercial wins highlight momentum across pulp, tissue, packaging, and wood composites, with strong cash reserves and a focus on converting trials to sales.